PDB73 - INDIRECT COST-EFFECTIVENESS ANALYSIS OF EMPAGLIFLOZIN COMPARED TO CANAGLIFLOZIN FOR PATIENTS WITH T2DM AND CARDIOVASCULAR DISEASE IN THE SPANISH NATIONAL HEALTH SERVICE
| Autor: | Carrasco Perez, M., Male, N., Serra Burriel, M., Pfarr, E., Kansal, A. |
|---|---|
| Zdroj: | In Value in Health October 2018 21 Supplement 3:S130-S130 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect